Jamie Weeks’ Founders Row has made a strategic investment in Ohm Health, makers of a screen-free nervous system device.
A closer look at how investors behind Function Health, Ammortal and Blueprint have created a model that gives accredited operators and executives access to selective…
Trubar's $173 million deal marks the latest acquisition in the protein gold rush, and seemingly everyone wants in.
SculptHouse has secured an investment from Jamie Weeks' Founders Row to expand its multi-revenue model to major U.S. markets.
Peloton forecast third-quarter revenue below Wall Street estimates, citing weak demand for its fitness equipment, sending its shares down 23%.
Willie Nelson’s THC drink brand Willie’s Remedy+ has raised $15 million and is set to roll out nationwide in retail.
Midi Health surpassed a $1 billion valuation following a $100 million Series D, highlighting increased capital flowing into women’s health.
Investment firm Apollo is acquiring a minority stake in Canada’s largest fitness club operator The GoodLife Group in a deal valued at around $1.46 billion.
As longevity and air quality concerns rise, Climatic has emerged from stealth mode with new funding and a soon-to-launch lung health product.
Virtuix has gone public on the Nasdaq Global Market, lining up new capital for its treadmill-like virtual reality (VR) movement platform.
Sign Up to Our Newsletter
